Navigation Links
Customer Elects to Forego Commercial Production of Product
Date:1/23/2010

IRVINE, Calif., Jan. 22 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) (the "Company") today announced that one of its customers has elected to not bring to market a product developed by Pro-Dex under a Development Agreement with such customer and, instead, will pay a $250,000 fee pursuant to its agreement with Pro-Dex.

As previously announced by the Company in past earnings conference calls, Pro-Dex has developed a new battery-powered shaver system for a major player in the spine segment of the orthopedic market.  This development work was completed in early 2009 for which Pro-Dex was paid approximately $200,000.  Since then, the customer has been addressing regulatory requirements related to, and assessing the changing market environment for, such product.  First year revenue to Pro-Dex from this new product had been estimated by Pro-Dex at $1.5 to $3.0 million and contingent on FDA approval of the system.

Pro-Dex has now been informed by the customer that, given the combined impact of 1) the lack of medical reimbursement for the clinical procedures in which this product is used, 2) the high cost of customer-developed consumable components involved in the procedure, and 3) the cost and restrictions related to the disposal of those consumable components, they are electing to abandon the commercialization of the new battery-powered product, opting instead to rely on the corded version of the device previously manufactured by Pro-Dex for them.

The Customer currently has approximately 200 of the earlier corded systems installed worldwide and has informed Pro-Dex that it intends to update those systems through the purchase of adapters manufactured by Pro-Dex.  The customer has also informed Pro-Dex that it intends to enter into a Service and Supply Agreement with Pro-Dex to support the existing corded systems already in the field, to purchase the adapters required to update those existing systems, and to define the terms under which new corded systems may be purchased from Pro-Dex.  The negotiation of this new Agreement is expected to take place in the next month and the specific terms are not yet known.

Commenting on this event, Mark Murphy, Pro-Dex's President and CEO said, "We are of course disappointed by our customer's decision.  We put significant effort into making this an extraordinary product and our customer agrees that we achieved that.  However, we understand the challenges they face in bringing this product to market and will support them in making the right decisions for their business.  They have assured us that Pro-Dex's performance on the project was exceptional and was not related to their decision to forego this product's production.  They further indicated that they would certainly use Pro-Dex again for future development projects, given their positive experience with our capabilities."

With the termination of the Development Agreement, the customer is paying Pro-Dex a $250,000 fee and have indicated they intend to make such a payment in the next month.  Accordingly, Pro-Dex anticipates that the payment will be recognized as revenue in its fiscal 3rd quarter.  Further, while the customer owns the resulting technology from Pro-Dex's development service, by not entering into a formal Supply Agreement with Pro-Dex to purchase the product containing that resulting technology, the customer foregoes the future right to commercialize any product containing the resulting technology, unless that product is made by Pro-Dex.  Pro-Dex continues to own all of the base technology contained in the product.

Pro-Dex, Inc., with operations in Irvine, California, Beaverton, Oregon and Carson City, Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.

For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.

SOURCE Pro-Dex, Inc.

RELATED LINKS
http://www.pro-dex.com

'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers
2. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
3. Siemens Delivers Images per the Customers Request - Images My Way
4. Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers
5. Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement
6. Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling
7. Oregon Tourism Commission Unveils New Online Customer Service Training Program
8. Apieron, Inc. Begins Customer Shipments of the Insight(TM) eNO System
9. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
10. Pfizer Selects ChemAxons Markush Platform
11. Northeast Alabama Regional Medical Center Selects Allscripts to Automate Emergency Department and Connect Caregivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):